// App-Quantinova.ai

BSH19‐PO‐014 : CD47 but Not Calreticulin Is over Expressed in Patients with Myeloproliferative Neoplasms

Researchers

Presenter

  • K. Boasman

Principal Investigators

  • M. Simmonds

  • C. Rinaldi

Medical Centers

  • Life Sciences, Lincoln University, Lincoln, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Polycythaemia vera

  • Acute Leukemia

  • Myelofibrosis

  • Solid malignancies

Biomarkers

  • Calreticulin

  • Cluster of Differentiation 47

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

  • Ruxolitinib phosphate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved